Emerging and evolving concepts in cancer immunotherapy imaging
Criteria based on measurements of lesion diameter at CT have guided treatment with
historical therapies due to the strong association between tumor size and survival. Clinical …
historical therapies due to the strong association between tumor size and survival. Clinical …
[HTML][HTML] Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies
A Dimitrakopoulou-Strauss, L Pan… - European Journal of …, 2023 - Springer
Long axial field of view (LAFOV) PET-CT scanners have been recently developed and are
already in clinical use in few centers worldwide. Although still limited, the hitherto acquired …
already in clinical use in few centers worldwide. Although still limited, the hitherto acquired …
[HTML][HTML] Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma
C Sachpekidis, L Pan, A Kopp-Schneider… - European Journal of …, 2023 - Springer
Aim The recent introduction of long axial field-of-view (LAFOV) PET/CT scanners has
yielded very promising results regarding image quality and sensitivity in oncological …
yielded very promising results regarding image quality and sensitivity in oncological …
Dual-Targeting PET Tracers Enable Enzyme-Mediated Self-Assembly for the PET Imaging of Legumain Activity
C Lu, K Li, H Xi, D Hua, H Li, F Gao… - ACS Applied Materials …, 2023 - ACS Publications
Legumain, a lysosomal cysteine protease overexpressed in a variety of tumors, has been
considered a promising biomarker for various cancers. Precise detection of legumain activity …
considered a promising biomarker for various cancers. Precise detection of legumain activity …
[HTML][HTML] Joint EANM-SNMMI guideline on the role of 2-[18F] FDG PET/CT in no special type breast cancer
SC Vaz, JPP Woll, F Cardoso, D Groheux… - European Journal of …, 2024 - Springer
Purpose To provide an organized, international, state-of-the-art, and multidisciplinary
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …
[HTML][HTML] Tumor response assessment on imaging following immunotherapy
AM Berz, C Dromain, N Vietti-Violi, S Boughdad… - Frontiers in …, 2022 - frontiersin.org
In recent years, various systemic immunotherapies have been developed for cancer
treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints …
treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints …
[HTML][HTML] Clinical application of immunoPET targeting checkpoint inhibitors
EM Abenavoli, F Linguanti, R Calabretta… - Cancers, 2023 - mdpi.com
Simple Summary Cancer treatment with immune checkpoint inhibitors (ICIs) has significantly
impacted patients' management and outcomes. To better assess the benefit of ICIs and …
impacted patients' management and outcomes. To better assess the benefit of ICIs and …
[HTML][HTML] The role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and monitoring of large vessel vasculitides-a review article
M Bahrami, H Mohammadi… - American Journal of …, 2023 - ncbi.nlm.nih.gov
In the last two decades, advancements in positron emission tomography (PET) technology
have increased the diagnostic accuracy of patients with large-vessel vasculitis (LVV) …
have increased the diagnostic accuracy of patients with large-vessel vasculitis (LVV) …
Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop
LK Shankar, H Schöder, E Sharon, J Wolchok… - The Lancet …, 2023 - thelancet.com
As the immuno-oncology field continues the rapid growth witnessed over the past decade,
optimising patient outcomes requires an evolution in the current response-assessment …
optimising patient outcomes requires an evolution in the current response-assessment …
[HTML][HTML] Beyond the Frontline: A Triple-Line Approach of Thoracic Surgeons in Lung Cancer Management—State of the Art
B Bottet, N Piton, J Selim, M Sarsam, F Guisier… - Cancers, 2023 - mdpi.com
Simple Summary Lung cancer is a heterogeneous disease, making it a complex and
challenging condition to diagnose and treat effectively. However, recent advances have …
challenging condition to diagnose and treat effectively. However, recent advances have …